Risikoadaptierte therapien bei der systemischen sklerose

Translated title of the contribution: Clinical risk-adapted therapies in systemic sclerosis

G. Riemekasten*, D. Dragun

*Corresponding author for this work
1 Citation (Scopus)


Systemic sclerosis is a challenging disease in terms of early risk assessment and the implications for therapy. The current article draws on a literature analysis and on personal experience of over 450 patients with systemic sclerosis and related illnesses, describing an attempt at a risk-adapted treatment strategy for patients with systemic sclerosis, and is intended to be used as a discussion paper. A major point of emphasis is on novel therapeutic options for patients who are refractory to current treatment strategies and who are at a high risk of serious complications or a limited prognosis. The paper also highlights possible future treatment options, including vasoactive, cellular and immune suppressant treatments.

Translated title of the contributionClinical risk-adapted therapies in systemic sclerosis
Original languageGerman
JournalZeitschrift fur Rheumatologie
Issue number8
Pages (from-to)672-678
Number of pages7
Publication statusPublished - 12.2007

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)


Dive into the research topics of 'Clinical risk-adapted therapies in systemic sclerosis'. Together they form a unique fingerprint.

Cite this